A Phase I/II Study Of Chimeric Antibody Against Interleukin-6 (CNTO 328) In Subjects With Metastatic Renal Cell Carcinoma

Project Details

Short titleA Phase I/II Study Of Chimeric Antibody Against Interleukin-6 (CNTO 328) In Subjects With Metastatic Renal Cell Carcinoma
StatusFinished
Effective start/end date1/01/0431/12/05

Funding

  • CENTOCOR INC